De-risking the Patient Journey in Cell Therapies

This guide outlines six critical risk nodes in the patient journey for cell therapies, including CAR T and TCR treatments. It provides actionable strategies to mitigate risks related to patient eligibility, clinical procedures, manufacturing delays, and long-term follow-up, ensuring a smoother clinical experience and better outcomes. Fortrea's expertise in designing and supporting cell therapy programs is highlighted, emphasizing the importance of patient-centric approaches and protocol flexibil